Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.05B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$404M |
| 3 |
AstraZeneca
AZN
|
+$342M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$288M |
| 5 |
Willis Towers Watson
WTW
|
+$227M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Icahn Enterprises
IEP
|
+$641M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$538M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$294M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.22% |
| 2 | Financials | 7.52% |
| 3 | Healthcare | 6.46% |
| 4 | Consumer Discretionary | 6.41% |
| 5 | Communication Services | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Flowers Foods
FLO
$1.58B
| $4.81M | ﹤0.01% |
198,689
+3,487
| +2% | +$84.7K |
|
1902
Moog Inc Class A
MOG.A
$12.4B
| $4.8M | ﹤0.01% |
57,055
+12,532
| +28% | +$1.08M |
|
1903
iShares MSCI ACWI ETF
ACWI
$32B
| $4.79M | ﹤0.01% |
47,388
-30,377
| -39% | -$3.03M |
|
1904
Power Integrations
POWI
$3.15B
| $4.79M | ﹤0.01% |
58,422
+25,695
| +79% | +$2.07M |
|
|
SNR
1905
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $4.79M | ﹤0.01% |
545,873
+291,559
| +115% | +$2.01M |
|
1906
Cytokinetics
CYTK
$10.6B
| $4.79M | ﹤0.01% |
241,835
+55,089
| +29% | +$1.29M |
|
1907
BioCryst Pharmaceuticals
BCRX
$2.42B
| $4.77M | ﹤0.01% |
301,814
-60,351
| -17% | -$820K |
|
1908
First Trust US Equity Opportunities ETF
FPX
$1.43B
| $4.77M | ﹤0.01% |
37,400
+7,130
| +24% | +$869K |
|
|
DMTK
1909
DELISTED
DermTech, Inc. Common Stock
DMTK
| $4.76M | ﹤0.01% |
114,549
+36,334
| +46% | +$1.49M |
|
1910
ProShares Russell US Dividend Growers ETF
TMDV
$4.82M
| $4.75M | ﹤0.01% |
100,000
| – | – |
|
|
TWO
1911
Two Harbors Investment
TWO
$1.27B
| $4.75M | ﹤0.01% |
157,126
+140,131
| +825% | +$4.17M |
|
|
TPTX
1912
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $4.75M | ﹤0.01% |
60,861
+18,942
| +45% | +$1.4M |
|
|
NSA
1913
DELISTED
National Storage Affiliates Trust
NSA
| $4.74M | ﹤0.01% |
93,849
-1,560
| -2% | -$71.4K |
|
1914
Organogenesis Holdings
ORGO
$324M
| $4.74M | ﹤0.01% |
285,110
+283,491
| +17,510% | +$5.28M |
|
1915
Opko Health
OPK
$1.02B
| $4.74M | ﹤0.01% |
1,169,296
-24,130
| -2% | -$94.6K |
|
|
JWN
1916
DELISTED
Nordstrom
JWN
| $4.73M | ﹤0.01% |
129,452
-300,607
| -70% | -$11M |
|
|
BEST
1917
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $4.73M | ﹤0.01% |
132,875
+1,567
| +1% | +$45K |
|
1918
CGI
GIB
$15.6B
| $4.72M | ﹤0.01% |
52,007
+31,416
| +153% | +$2.78M |
|
1919
uniQure
QURE
$2.75B
| $4.72M | ﹤0.01% |
153,241
+17,272
| +13% | +$579K |
|
1920
Invesco S&P 500 Pure Growth ETF
RPG
$1.9B
| $4.7M | ﹤0.01% |
127,595
-68,580
| -35% | -$2.36M |
|
1921
Darling Ingredients
DAR
$9.32B
| $4.7M | ﹤0.01% |
69,596
-9,396
| -12% | -$662K |
|
1922
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.51B
| $4.69M | ﹤0.01% |
49,654
+2,393
| +5% | +$224K |
|
1923
UGI
UGI
$7.87B
| $4.69M | ﹤0.01% |
101,325
-80,976
| -44% | -$3.64M |
|
1924
Southern Copper
SCCO
$138B
| $4.69M | ﹤0.01% |
78,674
-33,768
| -30% | -$2.19M |
|
1925
VEON
VEON
$3.5B
| $4.69M | ﹤0.01% |
102,508
+98,850
| +2,702% | +$4.36M |
|
Similar funds
Citigroup's Q2 2021 Portfolio in Review
As of Q2 2021, Citigroup held 6,654 positions worth $166B, up 7.5% from $155B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup's Q2 2021 filing shows 397 new, 2,681 increased, 2,205 reduced and 444 closed positions. Its largest new stake was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M. The largest sale was Icahn Enterprises, an estimated $641M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q2 2021 buy was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $2.05B increase.
- Citigroup's biggest Q2 2021 reduction was Icahn Enterprises, cutting an estimated $641M.
- Citigroup fully exited RealPage, Inc. in Q2 2021, selling an estimated $226M.
- Citigroup's ten largest holdings make up 20% of its $166B portfolio in Q2 2021.
- Citigroup opened 397 new positions and closed 444 in Q2 2021.
- Citigroup's portfolio value rose 7.5% quarter-over-quarter to $166B.
Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.